Soluble PD-L1 is associated with local and systemic inflammation markers in primary and secondary brain tumours

BACKGROUND: Immune-modulatory treatments have so far shown limited clinical activity in primary brain tumours. We aimed to investigate soluble programmed death receptor ligand 1 (sPD-L1) as systemic inflammation parameter in patients with brain tumour. METHODS: EDTA plasma was collected from 81 glio...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:ESMO Open
Autors principals: Mair, Maximilian J, Pajenda, Sahra, Ilhan-Mutlu, Aysegül, Steindl, Ariane, Kiesel, Barbara, Widhalm, Georg, Dieckmann, Karin, Feldmann, Katharina, Hainfellner, Johannes, Marosi, Christine, Müllauer, Leonhard, Wagner, Ludwig, Preusser, Matthias, Berghoff, Anna S
Format: Artigo
Idioma:Inglês
Publicat: BMJ Publishing Group 2020
Matèries:
Original Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7662140/
https://ncbi.nlm.nih.gov/pubmed/33184096
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/esmoopen-2020-000863
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars